It was demonstrated that sEVs derived from breast cancer-derived primary mesenchymal stem cells (MSCs) induce differentiation of monocytic myeloid-derived suppressor cells (M-MDSCs) into M2-polarized macrophages and the upregulation of PD-L1 expression. The gene discussed is CD274; the disease is breast cancer.